Analysis of methyltransferases in kidney cancer, including ccRCC, indicates that both METTL3 and METTL14 are tumor suppressors in this disease (Gong et al., 2019; Li et al., 2017a; Wang et al., 2019; Zhou et al., 2019). This evidence concerns the gene METTL14 and kidney cancer.